Sector updates in March

< 1 minute read

Investment firms 

  • Shanghai Fosun Pharmaceutical Co. Ltd has formed a partnership with seven other investors to form an investment fund that plans to invest ¥5 billion (US$695M) in local biotech and med-tech companies in Shenzhen, China
  • UK healthcare investor RYSE Asset Management has closed a new fund to support start-ups involved in digital health and care technologies, raising $50 million 



  • Adam Barker has been appointed to Director of Investor Relations and Corporate Development at RESET Health, he was previously Head of Healthcare Equity Research at Goodbody  
  • Dylan Sadie has been appointed Associate Analyst at Hybridan LLP  



  • Emily Craig has been appointed Senior Health Writer at The Daily Telegraph 
  • Alice Wilkinson has been appointed Deputy Head of Health Features at The Daily Telegraph 
  • Arno Schuetze has been appointed Finance Correspondent at Bloomberg (EMEA) 
  • Josée Rose has been appointed Chief Editor, Americas at Dow Jones Newswires for The Wall Street Journal (US) 
  • Oliver Barnes has been appointed US Pharmaceutical & Biotech Correspondent at the Financial Times 
  • Rob White has been appointed Money Writer at The Daily Telegraph 
  • Marianne Gros has been appointed Sustainability Reporter at POLITICO (EU) 
  • Pamela Barbaglia has joined Bloomberg (Deals Reporter) covering European M&A with a focus on France and Benelux 
  • Marina Temkin has been appointed Venture Capital and Startup Reporter at TechCrunch (US) 
  • Ian Bolland has left his role as Editor at Med-Tech Innovation